Invest in inflation-protected debt securities to safeguard against rising inflation. Allocate funds to floating rate loans to benefit from increasing interest rates. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Average growth of 7% a year over the last 4 years. Red columns mark years that ended in a loss.
This company is not turning a profit, so the market is pricing its sales instead: 26.7× for every dollar of annual revenue.
No analyst target is on record for this company.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Sales run at $18.7M a year. A small number, but proof the product has real buyers.
It pays out $0.43 per share each year — regular cash for whoever holds the stock.
A loss of $250.6M against $18.7M in annual sales.
We grade companies — revenue, margins, balance sheets. This is a fund, so there is no report card to give. That is not a low grade; it is a different kind of thing.
One-line summary: a basket, not a business. Judge it by what it holds.